Hana Hassanin

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

Katrina M. Pollock, Hannah M. Cheeseman, Alexander J. Szubert et al. · EClinicalMedicine · 2022 · 162 citations · Full text

Pharmacy, Biotechnology, Immunology +16

Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial

Frances Priddy, David Lewis, Hana Hassanin et al. · The Lancet HIV · 2019 · 134 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The arteries of the humeral head and their relevance in fracture treatment

C Meyer, Volker Alt, Hana Hassanin et al. · Surgical and Radiologic Anatomy · 2005 · 102 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial

Rajeka Lazarus, Benedicte Querton, Irena Corbic Ramljak et al. · The Lancet Infectious Diseases · 2022 · 48 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17